Filter posts

New Reports: Insurance Plans Shifting More Costs to Patients

A new report out this week from the Kaiser Family Foundation showed that patient out …

New Report Emphasizes the Role of Patent Protection in the Global Diffusion of New Drugs

A new report from the National Bureau of Economic Research (NBER) has determined that strong …

Washington Post: Why Extremely Expensive Drugs Are Often Worth the Cost

Jason Millman highlights a new study published in Health Affairs showing specialty drugs often provide …

WSJ Editorial: The Medical Innovation Threat

An editorial in today’s Wall Street Journal looks at the rising threat the American insurance industry’s …

NYT Columnist: Insurance Industry “Looking at the Costs of Sovaldi in the Wrong Way”

Margot Sanger-Katz’s article on a new drug that treats hepatitis C notes that despite the …

The Cancer Death-Panel App

In an article for the New York Post, Robert Goldberg, vice president of the Center …

India Compulsory License: A Times of India Article Says It's Not Helping the Poor

India recently issued a compulsory license on Bayer’s liver and kidney cancer drug (Sorafenib) with …